In An FDA First, Cardiac Gene Therapy Given RMAT Status
The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of...
Bacterial Compound Can Help Halt Influenza Virus Cloning
University of Bonn researchers have come across a new bacterial compound that may very well impede the replication of the influenza virus.
Notably, viruses use...
Dustiness of HPAPI In Sealed System Can Be Predicted Now
Scientists have shown that a recently developed two-chamber setup (TCS) for containment investigations that consists of an emission chamber as well as a detection...
Identifying The Tumour With Fluorescence Guided Surgery
Consultant Orthopaedic Oncologist and Honorary Senior Lecturer at the Newcastle University, Dr. Kenneth Rankin has decided to reunite with his fellow specialists across the...
OA Progression Gauged By Use of Plasma Proteomics Signature
The progression of osteoarthritis, which is based on the marker of cartilage degeneration as well as pain, can be forecasted by using the plasma...
30% Lesser Side Effects, Thanks To The DNA Medication Pass
The Lancet study is the first to showcase the practical use of prescription medications based on an individual's genetic information.
The one-size-fits-all approach to pharmaceutical...
Twelve Digit National Drug Code Gets Proposed By The FDA
All labelling pertaining to the products that carry the national drug code will have to be updated if in case the FDA finalises its...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...